Clinical trials in Siauliai – page 2

24 clinical trials in Siauliai, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in LithuaniaKlinikiniai-Tyrimai.lt

Siauliai at a glance

clinical trials

Research sites0

Quick filters

24 trials in Siauliai

Open in trial search

Rheumatoid arthritis

Not recruiting

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Lithuania

Participants:18–64 years · 65+ years
Substances:Abatacept
Sponsor:Dr Reddy's Laboratories Limited

Contact Research Centre

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Lithuania

Participants:18–64 years · 65+ years
Substances:Atorvastatin
Sponsor:Novartis Pharma AG

Contact Research Centre

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:Asundexian
Sponsor:Bayer AG

Contact Research Centre

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug

Lithuania

Participants:18–64 years · 65+ years
Substances:Inclisiran
Sponsor:Novartis Pharma AG

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Registered drugNo placebo

Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Registered drugNo placebo

Lithuania

Participants:18–64 years · 65+ years
Substances:Adalimumab
Sponsor:Eli Lilly & Co.

Contact Research Centre

Pneumonia+1

Not recruiting

A study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia

Investigational

A study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:Trimodulin (Human Igm, Iga, Igg Solution)
Sponsor:Biotest GmbH & Co. KGaA

Contact Research Centre

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:Ziltivekimab
Sponsor:Novo Nordisk A/S

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Investigational

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Conjunctivitis allergic

Not recruiting

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug

Lithuania

Participants:0–17 years
Substances:Betula Pollen Extract
Sponsor:Stallergenes

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Lithuania

Participants:18–64 years
Substances:Charcoal, Activated
Sponsor:Novartis Pharma AG

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Lithuania

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Bayer AG

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational

Lithuania

Participants:18–64 years · 65+ years
Substances:Tanimilast
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

Other cities in Lithuania

The busiest research cities in the country

All 10 cities in Lithuania

Clinical research in Siauliai

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on cardiovascular disease prevention and treatment, including studies of new medications for stroke prevention and heart attack management.

Stroke Prevention in Atrial Fibrillation
Acute Myocardial Infarction Treatment
Atherosclerotic Disease Management

Groundbreaking research evaluating novel compounds like asundexian and inclisiran for cardiovascular protection.

02 Autoimmune Conditions

Comprehensive studies addressing various autoimmune disorders, with particular focus on innovative therapeutic approaches.

Rheumatoid Arthritis Treatment
Psoriatic Arthritis Management
Sjögren's Syndrome Therapy

Advanced trials testing new biological agents and biosimilars for improved disease control.

03 Neurological Studies

Leading-edge research in multiple sclerosis and related neurological conditions, exploring new treatment pathways.

Multiple Sclerosis Therapies
Long-term Treatment Safety
Disease-Modifying Treatments

Evaluating innovative medications like remibrutinib and tolebrutinib for enhanced therapeutic outcomes.

04 Metabolic Disorders

Research focusing on lipid disorders and metabolic conditions, investigating novel therapeutic approaches.

Hypertriglyceridemia Management
Lipid Level Control
Metabolic Disease Treatment

Studies evaluating new compounds for managing severe metabolic conditions.

Back to Lithuania All countries